Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Superficial venous ablation · Michigan | Superficial venous ablation · Illinois | |
|---|---|---|
| Surgeons, 2024 | 44 | 97 |
| Medicare fee-for-service cases | 2,935 | 8,273 |
| Growth since 2019 (Medicare FFS) | −15%/yr | −2.9%/yr |
| Forecast cases (Medicare FFS) | 2,850 in 2030 | 9,750 in 2030 |
| Forecast growth | −0.5%/yr to 2030 | +2.8%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 3.3 | 5.8 |
| Medicare Advantage share | 66% | 47% |
| Out of hospital | 95% (+1 pts since 2019) | 94% (+0 pts since 2019) |
| Cases per surgeon | 67 | 85 |
| Top 10 surgeons' share | 54% | 36% |
| Surgeons growing | 5 | 20 |
| New since the base year | 12 | 29 |
| Likely to stop billing it | 11 by 2026 | 17 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $541 | $589 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.